# Caffeine and Prophylactic Noradrenaline Requirement During Cesarean Delivery

> **NCT07655245** · NA · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 62 (estimated)

## Conditions studied

- Spinal Hypotension
- Vasopressor

## Interventions

- **DRUG:** Caffeine (200 mg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07655245
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-16
- **Primary completion:** 2026-09-16
- **Final completion:** 2026-09-19
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655245, "Caffeine and Prophylactic Noradrenaline Requirement During Cesarean Delivery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*